Metropolis Healthcare Limited has informed the Exchange about Grant of Stock Benefits
METROPOLIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
The Nomination and Remuneration Committee approved allotment of 4,200 equity shares at INR 2 per share under the MHL-RSU Plan 2020, aggregating INR 8,400. Additionally, the Committee granted 14,236 RSUs under the Metropolis-RSU Plan 2025 and 2,12,345 stock options under the Metropolis-ESOP Plan 2025. The RSU grant carries an exercise price of INR 2 (face value), while the ESOP options are priced at INR 375.62 per option. Both schemes have a vesting period of 1 to 4 years, with a maximum exercise window of 5 years from vesting. The newly allotted shares will rank pari-passu with existing equity shares, with 50% subject to a 1-year lock-in.
Minor equity dilution from 4,200 new shares, representing negligible impact on total share count of 20.73 crore shares. The stock benefit grants are a standard ESOP mechanism for employee retention and align employee interests with shareholder value.